Study of RMC-6291 in Combination with RMC-6236 in Participants with Advanced KRAS G12C Mutant Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Interventions
DRUG

Assigned interventions

Drug: RMC-6291 and RMC-6236 Oral tablets

Trial Locations (54)

10032

RECRUITING

Columbia University, New York

RECRUITING

NYU Langone Health, New York

10043

RECRUITING

San Luigi Hospital, Orbassano

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

20162

RECRUITING

Niguarda Cancer Center, Milan

22031

RECRUITING

NEXT Oncology Virginia, Fairfax

28027

RECRUITING

University Clinic of Navarra, Madrid

28033

RECRUITING

Fundacion MD Anderson Cancer Center, Madrid

28040

RECRUITING

START Madrid, Madrid

28041

RECRUITING

Hosptial Universitario 12 de Octubre, Madrid

28223

RECRUITING

NEXT Oncology - Quirónsalud Madrid University Hospital, Madrid

31008

RECRUITING

University Clinic of Navarra, Pamplona

33000

RECRUITING

Institut Bergonie, Bordeaux

33081

RECRUITING

Centro Di Riferimento Oncologico, Aviano

33612

RECRUITING

Moffitt Cancer Center and Research Institute, Tampa

34232

RECRUITING

Florida Cancer Specialists, Sarasota

34298

RECRUITING

Cancer Institute of Montpellier, Montpellier

37203

RECRUITING

Sarah Cannon Research Institue, Nashville

41009

RECRUITING

Hosptial Universitario Virgen Macarena, Seville

44093

RECRUITING

CHU Nantes, Nantes

46026

RECRUITING

La Fe University and Polytechnic Hospital, Valencia

47014

RECRUITING

Institute Romagnolo per lo Studio Tumori, Meldola

47441

RECRUITING

Krankenhaus Bethanien Moers, Moers

48121

RECRUITING

AUSL Romagna - S.M. delle Croci Hospital, Ravenna

48202

RECRUITING

Henry Ford Cancer, Detroit

49055

RECRUITING

West Cancer Institute, Angers

49546

RECRUITING

START Midwest, Grand Rapids

50009

RECRUITING

Hospital Universitario Miguel Servet, Zaragoza

53226

NOT_YET_RECRUITING

Medical College of Wisconsin, Milwaukee

59000

RECRUITING

Oscar Lambret Center of Lillle, Lille

60126

RECRUITING

Department of Medical Oncology - Azienda Ospedaliero Uniersitaria delle Marche, Ancona

67033

RECRUITING

Institute of Cancer of Strasbourg, Strasbourg

69373

RECRUITING

Centre Leon Berard, Lyon

69500

RECRUITING

Hospital Louise Pradel, Bron

73104

RECRUITING

University of Oklahoma, Oklahoma City

73730

RECRUITING

Klinikum Esslingen GmbH, Esslingen am Neckar

75039

RECRUITING

NEXT Dallas, Irving

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

77030

RECRUITING

MD Anderson, Houston

78229

RECRUITING

NEXT Oncology San Antonio, San Antonio

RECRUITING

START Texas, San Antonio

80045

RECRUITING

University of Colorado Cancer Center, Aurora

80131

RECRUITING

"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli

80937

RECRUITING

Universitäts Klinikum Köln, Cologne

90419

RECRUITING

Klinkum Nurnberg Paracelsus Medical Unviersity, Nuremberg

91010

RECRUITING

City of Hope, Duarte

92868

RECRUITING

UC IRVINE Health, Orange

94305

RECRUITING

Stanford Cancer Institute, Stanford

95817

RECRUITING

UC Davis Comprehensive Cancer Center, Sacramento

02215

RECRUITING

Dana Farber Cancer Institute, Boston

1066CX

RECRUITING

Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam

00935

RECRUITING

Pan American Center for Oncology Trials, San Juan

08023

RECRUITING

START Barcelona - Hospital HM Nou Delfos, Barcelona

08908

RECRUITING

Institut Catala d'Oncologia Hospital, Barcelona

All Listed Sponsors
lead

Revolution Medicines, Inc.

INDUSTRY